The Enterprise Value as of December 2024 (TTM) for Kazia Therapeutics Limited (KZIA) is 15.14M

According to Kazia Therapeutics Limited’s latest financial reports and current stock price. The company's current Enterprise Value is 15.14M. This represents a change of -90.74% compared to the average of 163.42M of the last 4 quarters.

Kazia Therapeutics Limited (KZIA) Historical Enterprise Value (quarterly & annually)

How has KZIA Enterprise Value performed in the past?

The mean historical Enterprise Value of Kazia Therapeutics Limited over the last ten years is 1.83B. The current 15.14M Enterprise Value has changed -17.50% with respect to the historical average. Over the past ten years (40 quarters), KZIA's Enterprise Value was at its highest in in the September 2021 quarter at 20.65B. The Enterprise Value was at its lowest in in the June 2024 quarter at -1023000.00.

Kazia Therapeutics Limited (KZIA) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Kazia Therapeutics Limited Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Kazia Therapeutics Limited (KZIA) Average Enterprise Value

How has KZIA Enterprise Value performed in the past?

The current Enterprise Value of Kazia Therapeutics Limited (KZIA) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Kazia Therapeutics Limited (KZIA) Enterprise Value vs. Peers

How is KZIA’s Enterprise Value compared to its peers?

Kazia Therapeutics Limited’s Enterprise Value is less than CytomX Therapeutics, Inc. (58.45M), less than Assembly Biosciences, Inc. (70.75M), less than Ocular Therapeutix, Inc. (990.54M), greater than Spero Therapeutics, Inc. (-20208271.00), greater than Achilles Therapeutics plc (-35166954.00), less than SELLAS Life Sciences Group, Inc. (50.63M), greater than NLS Pharmaceutics AG (5.76M), less than Mereo BioPharma Group plc (503.96M), greater than Aravive, Inc. (-3158140.00), less than Day One Biopharmaceuticals, Inc. (880.76M), less than ZIVO Bioscience, Inc. (67.07M), less than RenovoRx, Inc. (21.16M), greater than Pasithea Therapeutics Corp. (-5827838.00), greater than Quoin Pharmaceuticals, Ltd. (-293957.00), greater than ARCA biopharma, Inc. (1.56M), less than Bionomics Limited (1.43B), less than OKYO Pharma Limited (35.43M), less than Candel Therapeutics, Inc. (407.31M), less than Anebulo Pharmaceuticals, Inc. (40.61M), greater than Cingulate Inc. (5.68M), less than Nurix Therapeutics, Inc. (1.34B), less than Seer, Inc. (118.01M), less than Quantum-Si incorporated (278.39M), less than HCW Biologics Inc. (27.62M), less than MediciNova, Inc. (53.56M),

Build a custom stock screener for Kazia Therapeutics Limited (KZIA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Kazia Therapeutics Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Kazia Therapeutics Limited (KZIA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Kazia Therapeutics Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.